Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway

BACKGROUND: Myocardial ischemia/reperfusion (I/R) injury is a severe heart problem resulting from restoring coronary blood flow to the myocardium after ischemia. This study is aimed at ascertaining the therapeutic efficiency and action mechanism of bardoxolone methyl (BARD) in myocardial I/R injury....

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Anwu, Wang, Zhaolin, Tang, Hua, Jia, Zhuyin, Ji, Xiaojun, Yang, Xuehua, Jiang, Wenbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977528/
https://www.ncbi.nlm.nih.gov/pubmed/36874247
http://dx.doi.org/10.1155/2023/5693732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977528/
https://www.ncbi.nlm.nih.gov/pubmed/36874247
http://dx.doi.org/10.1155/2023/5693732

Ejemplares similares